A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : QALY

Search Conditions:
Search Keyword : QALY
Search Method : Exact match.
Research Area:

Abbreviation: QALY
Appearance Frequency: 4287 time(s)
Long forms: 16

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
quality-adjusted life-year
(4217 times)
(449 times)
ICER (953 times)
ICERs (268 times)
WTP (164 times)
1985 Parameter estimates for a QALY utility model.
quality-adjusted life expectancy
(12 times)
Health Services
(3 times)
ICER (3 times)
3D-CRT (1 time)
ADR (1 time)
1994 Therapy for idiopathic membranous nephropathy: tailoring the choice by decision analysis.
cost-per-quality-adjusted life year
(9 times)
Health Services
(2 times)
DALY (2 times)
ICERs (2 times)
NICE (2 times)
2008 The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process.
quality of life year
(9 times)
(2 times)
ICER (4 times)
ACS (1 time)
BC (1 time)
2004 Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.
quality-adjusted LY
(8 times)
Health Services
(2 times)
LY (6 times)
ICERs (2 times)
mCRC (2 times)
2005 Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.
quality-of-life adjusted life year
(6 times)
(1 time)
ACCI (1 time)
AF (1 time)
BBF (1 time)
2000 The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis.
quality of life
(5 times)
Acquired Immunodeficiency Syndrome
(1 time)
ICER (2 times)
AI (1 time)
BMT (1 time)
2007 Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease.
quality-adjusted year of life
(5 times)
Vascular Diseases
(1 time)
AMI (1 time)
CI (1 time)
HPV (1 time)
2001 Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis.
(4 times)
(2 times)
BIA (1 time)
CrAg (1 time)
CRAG-LFA (1 time)
2015 [Clinical and economic benefits of the new antidiabetic drugs in the Czech Republic].
10  quality life year
(3 times)
(1 time)
COVID-19 (1 time)
ETV (1 time)
LVD (1 time)
2009 Cost-effectiveness of entecavir versus lamivudine for the suppression of viral replication in chronic hepatitis B patients in Brazil.
11  quality of life impact
(2 times)
Communicable Diseases
(1 time)
CER (1 time)
LVAD (1 time)
1999 [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City].
12  quality-adjusted survival
(2 times)
(1 time)
BCBM (1 time)
CI (1 time)
NHS (1 time)
2006 Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases.
13  quality-associated life year
(2 times)
Female Urogenital Diseases
(1 time)
ASC (1 time)
DS (1 time)
ICER (1 time)
2013 The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis.
14  cost-per-quality life year
(1 time)
Pharmacological Phenomena
(1 time)
ICER (1 time)
ISPOR (1 time)
2019 ICER, ISPOR AND QALYs: Tales of Imaginary Worlds.
15  QoL-adjusted life year
(1 time)
Vascular Diseases
(1 time)
QoL (1 time)
2011 Cost and cost-effectiveness of cardiac surgery in elderly patients.
16  Quality Adjusted Life Year calculations
(1 time)
(1 time)
TTO (1 time)
2012 Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies.